Every 424B that Radnet (RDNT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RDNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RDNT filings page.
RadNet, Inc. is registering for resale up to 34,069 shares of common stock that are to be released and issued to former shareholders of See-Mode Technologies Pte. Ltd. as the share component of a contingent milestone payment under a June 2, 2025 share purchase agreement. These See-Mode Shares relate to a US$4,203,462.24 contingent amount tied to specified FDA 510(k) milestones for a breast ultrasound detection product and are being registered pursuant to contractual registration rights. No proceeds from any resale will go to RadNet; selling stockholders receive all proceeds while RadNet bears registration expenses.
RadNet is a U.S. diagnostic imaging provider with 442 centers as of June 30, 2026 and a growing Digital Health segment branded DeepHealth. For the six months ended June 30, 2026, Imaging Centers net revenues were $1,198 million, compared with $970 million in the prior-year period.
RadNet, Inc. is registering the resale of up to 190,924 shares of common stock issued to the former owners of Cimar (UK) Limited as the non-cash portion of the purchase price under a November 10, 2025 share purchase agreement.
The Cimar Sellers received stock equal to half of approximately £20.1 million due at closing, and this filing satisfies their registration rights so they can sell those shares over time. RadNet will not receive any proceeds from these sales, though it is paying the registration and related expenses. The selling stockholders may dispose of shares through various public or private sale methods at market, fixed, or negotiated prices.
RadNet, Inc. registered 59,444 shares of common stock for resale by selling stockholders tied to its acquisition of substantially all assets of Remote Diagnostic Imaging Partners (RDIP). The registered amount includes 56,472 Initial Shares issued at closing on October 1, 2025 and up to 2,972 Holdback Shares withheld for 12 months to secure RDIP indemnification obligations.
RadNet will not receive any proceeds from these sales; any proceeds go to the selling stockholders. Sales may occur via ordinary brokerage transactions, block trades, privately negotiated deals, hedging, or short sales after the registration statement is declared effective. The company will bear registration expenses, while selling holders cover selling commissions and related costs.
As context, shares outstanding were 77,101,597 as of October 15, 2025. The RDIP purchase price was approximately $4.5 million, consisting of the share consideration and assumed liabilities, plus reimbursements of $5,700 and $13,000. Examples of per‑holder amounts being offered include Neil G. Huber 14,861 and Peter G. Jablonka 14,861. RadNet’s stock last closed at $76.93 on October 17, 2025 under “RDNT.”